Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Dell Technologies Capital contributed to a $12m round for silicon-based lidar chip developer Silc alongside Decent Capital and Itic Ventures.

Bio-fungicide and pesticide developer Biotalys has added $11.3m to a Globalchem-backed round now totalling $50.9m.

MIT Media Lab-affiliated E14 Fund has invested in the biomanufacturing software provider as part of a series A round led by Cultivian Sandbox Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

ABB Technology Ventures and NEC took part in a $60m series B round that will support the AI processor developer’s global expansion efforts.

The IoT security software provider has raised $50m in total, Kaiser Permanente Ventures and Mayo Clinic having boosted its series B round to a likely $33.5m.

Japan Post Capital contributed to a $26.4m round for the direct-to-consumer marketing and human resources technology provider, bringing its total funding to more than $62m.

ING Ventures and Uniqa Ventures co-led a second tranche of the business finance provider's series A round, which has closed at $24.9m.

Cinclus Pharma has lured back corporate venturing unit Recipharm Venture Fund for a $26.4m round that will fund a phase 2 study for its GERD therapy candidate.